Drägerwerk Achieves Record Sales in 2025, Sets Positive Outlook for 2026

Drägerwerk AG & Co. KGaA reported record net sales for 2025, marking a 5.3% increase, adjusted for currency effects. This growth was slightly higher than the previous forecast. Net sales reached EUR 3,482 million, eclipsing the 2024 figure of EUR 3,370.9 million.

Both the medical and safety divisions contributed to this success. The medical division saw a significant rise of 7.4%, while the safety division grew by 2.5%. The company's EBIT surged to a range of EUR 226 to 236 million, improving the EBIT margin to 6.5-6.8%.

Order intake also increased, with a notable 7.9% growth. In line with the company's dividend policy, Dräger plans to distribute around 30% of net profit to shareholders. For 2026, Dräger forecasts a net sales increase of 1.0-5.0% and an EBIT margin of 5.0-7.5%.